Literature DB >> 24321617

Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.

Seung-Nam Kim1, Ah-Reum Doo2, Ji-Yeun Park2, Hyunwoo J Choo3, Insop Shim2, Jongbae J Park4, Younbyoung Chae1, Bena Lee5, Hyejung Lee1, Hi-Joon Park6.   

Abstract

This study first showed the behavioural benefits of novel combination therapy of L-dopa with acupuncture on Parkinson's disease, and its underlying mechanisms within basal ganglia. The previous study reported that acupuncture may improve the motor function of a Parkinson's disease (PD) mouse model by increasing the dopamine efflux and turnover ratio of dopamine. Hence, we hypothesised that combining L-dopa with acupuncture would have a behavioural benefit for those with PD. We performed unilateral injections of 6-OHDA into the striatum of C57Bl/6 mice to model hemi-Parkinsonian attributes. To test motor function and dyskinetic anomalies, we examined cylinder behaviour and abnormal involuntary movement (AIM), respectively. We found that (1) a 50% reduced dose of L-dopa (7.5 mg/kg) combined with acupuncture showed an improvement in motor function that was comparable to mice given the standard dose of L-dopa treatment (15 mg/kg) only, and that (2) the combination treatment (L-dopa +acupuncture) was significantly superior in reducing AIM scores when equivalent doses of L-dopa were used. The combination treatment also significantly reduces the abnormal increase of GABA contents in the substantia nigra compared to the standard L-dopa treatment. Furthermore, abnormal expression of FosB, the immediate early gene of L-dopa induced dyskinesia (LID), was mitigated in the striatum by the combination treatment. All of these results indicate that acupuncture enhances the benefits of L-dopa on motor function with reduced dose of L-dopa and alleviating LID by normalising neurochemical imbalance within the basal ganglia.
© 2013 Published by Elsevier B.V.

Entities:  

Keywords:  Acupuncture; FosB; GABA; Levodopa-induced dyskinesia; Parkinson's disease; l-dopa combination treatment

Mesh:

Substances:

Year:  2013        PMID: 24321617      PMCID: PMC4180515          DOI: 10.1016/j.brainres.2013.11.028

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

1.  "Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease.

Authors:  Roger Kurlan
Journal:  Neurology       Date:  2005-03-08       Impact factor: 9.910

2.  Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia.

Authors:  Emanuela Santini; Emmanuel Valjent; Alessandro Usiello; Manolo Carta; Anders Borgkvist; Jean-Antoine Girault; Denis Hervé; Paul Greengard; Gilberto Fisone
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

3.  Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.

Authors:  Rakesh Kumar; Lindsay R Riddle; Suzy A Griffin; Wenhua Chu; Suwanna Vangveravong; Janet Neisewander; Robert H Mach; Robert R Luedtke
Journal:  Neuropharmacology       Date:  2009-02-05       Impact factor: 5.250

4.  Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake.

Authors:  P Popoli; R Reggio; A Pèzzola
Journal:  Neuropsychopharmacology       Date:  2000-05       Impact factor: 7.853

5.  Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels.

Authors:  Simone Bido; Matteo Marti; Michele Morari
Journal:  J Neurochem       Date:  2011-08-05       Impact factor: 5.372

6.  Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias.

Authors:  Torun Malmlöf; Daniella Rylander; Rudolf-Giesbert Alken; Frank Schneider; Torgny H Svensson; M Angela Cenci; Björn Schilström
Journal:  Exp Neurol       Date:  2010-07-24       Impact factor: 5.330

7.  Phosphatidylinositol 3-kinase/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of Parkinson's disease.

Authors:  Seung-Nam Kim; Seung-Tae Kim; Ah-Reum Doo; Ji-Yeun Park; Woongjoon Moon; Younbyoung Chae; Chang Shik Yin; Hyejung Lee; Hi-Joon Park
Journal:  Int J Neurosci       Date:  2011-07-19       Impact factor: 2.292

8.  Low-dose L-dopa therapy in Parkinson's disease: a 6-year follow-up study.

Authors:  W H Poewe; A J Lees; G M Stern
Journal:  Neurology       Date:  1986-11       Impact factor: 9.910

Review 9.  Description of Parkinson's disease as a clinical syndrome.

Authors:  Stanley Fahn
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

10.  Parsing brain activity associated with acupuncture treatment in Parkinson's diseases.

Authors:  Younbyoung Chae; Hyejung Lee; Hackjin Kim; Chang-Hwan Kim; Dae-Il Chang; Kyung-Mi Kim; Hi-Joon Park
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

View more
  12 in total

Review 1.  Mechanisms for alternative treatments in Parkinson's disease: acupuncture, tai chi, and other treatments.

Authors:  Bijan D Ghaffari; Benzi Kluger
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

2.  Novel Neuroprotective Effects of Melanin-Concentrating Hormone in Parkinson's Disease.

Authors:  Ji-Yeun Park; Seung-Nam Kim; Junsang Yoo; Jaehwan Jang; Ahreum Lee; Ju-Young Oh; Hongwon Kim; Seung Tack Oh; Seong-Uk Park; Jongpil Kim; Hi-Joon Park; Songhee Jeon
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

Review 3.  Acupuncture points for treating Parkinson's disease based on animal studies.

Authors:  Sunoh Kwon; Byung-Kwan Seo; Seungtae Kim
Journal:  Chin J Integr Med       Date:  2016-07-26       Impact factor: 1.978

Review 4.  Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Authors:  Song Li; Jie Dong; Cheng Cheng; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2016-08-11       Impact factor: 3.575

Review 5.  Professional ethics in complementary and alternative medicines in management of Parkinson's disease.

Authors:  Hee Jin Kim; Beomseok Jeon; Sun Ju Chung
Journal:  J Parkinsons Dis       Date:  2016-10-19       Impact factor: 5.568

Review 6.  Research advances in treatment of neurological and psychological diseases by acupuncture at the Acupuncture Meridian Science Research Center.

Authors:  Bombi Lee; Seung-Nam Kim; Hi-Joon Park; Hyejung Lee
Journal:  Integr Med Res       Date:  2014-04-01

7.  Study on Effect of Striatal mGluR2/3 in Alleviating Motor Dysfunction in Rat PD Model Treated by Exercise Therapy.

Authors:  Ping Chen; Xiaodong Li
Journal:  Front Aging Neurosci       Date:  2019-10-02       Impact factor: 5.750

8.  Effects of Combined Treatment with Acupuncture and Chunggan Formula in a Mouse Model of Parkinson's Disease.

Authors:  Tae-Yeon Hwang; Min-A Song; Sora Ahn; Ju-Young Oh; Dong-Hee Kim; Quan Feng Liu; Wonwoong Lee; Jongki Hong; Songhee Jeon; Hi-Joon Park
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-21       Impact factor: 2.629

9.  Acupuncture on GB34 activates the precentral gyrus and prefrontal cortex in Parkinson's disease.

Authors:  Sujung Yeo; Il-Hwan Choe; Maurits van den Noort; Peggy Bosch; Geon-Ho Jahng; Bruce Rosen; Sung-Hoon Kim; Sabina Lim
Journal:  BMC Complement Altern Med       Date:  2014-09-15       Impact factor: 3.659

Review 10.  Acupuncture for Parkinson's Disease: Efficacy Evaluation and Mechanisms in the Dopaminergic Neural Circuit.

Authors:  Yadan Zhao; Zichen Zhang; Siru Qin; Wen Fan; Wei Li; Jingyi Liu; Songtao Wang; Zhifang Xu; Meidan Zhao
Journal:  Neural Plast       Date:  2021-06-15       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.